Non-anti-arrhythmic drugs have the potential to cause QT prolongation and pro-arrhythmia, necessitating careful clinical and regulatory oversight.
Tasa de eventos absoluta: 0% vs 0%
1 1.Preamble mal presentations.The speakers were chosen for their particular competence in the relevant field.Furthermore, The Policy Conference on The Potential for QT selected topics were discussed in detail in separate work-Prolongation and Pro-arrhythmia by Non-anti-arrhythmic shops.This document represents the executive summary of Drugs.
Wilhelm Haverkamp (Tue,) reported a other. Non-anti-arrhythmic drugs have the potential to cause QT prolongation and pro-arrhythmia, necessitating careful clinical and regulatory oversight.